Earlier this year, this column focused on three of the hottest papers of 1996. Between them they identified one of the holy grails of AIDS researchers for the past 10 years: the cofactors that human immunodeficiency virus (HIV) needs to infect cells. At that time (Science Watch, 8[3]:7, May/June 1997) the three papers were sitting just below the Top Ten. They are now safely ensconced at #1, #3, and #4; what is gratifying is that the research that inspired them is on the list at #6, while two papers that take the cofactor findings further are at #7 and #10. Robert Gallo, Director of the Institute of Human Virology at the University of Maryland in Baltimore, and his colleagues, published a report in December of 1995 in Science that showed that three chemokines-molecules involved in the inflammatory responses of the immune system-were able to suppress infection by HIV (paper #6). The three, known as RANTES, MIP-1 a and MIP-1b, pointed researchers at a receptor called CKR-5, because it was the one chemokine receptor that was known to bind all three HIV suppressants. Thus it was that first fusin (#1), and, within a couple of weeks, CKR-5 (#3 and #4), were positively identified as the coreceptors that HIV needs (in addition to CD4) to fuse with host cells.The fusin paper by National Institutes of Health researcher Edward A. Berger and colleagues was sent to Science in March of 1996; by the time it was published in May his group had also identified CKR-5 as another cofactor (though not in time to win that race too). That is the paper currently at #7. At #10 is work from Robert Doms's group in the Department of Pathology and Laboratory Medicine, University of Pennsylvania. This helps to make sense of changes shown by HIV as the infection proceeds. Viruses isolated shortly after an individual becomes positive for HIV tend to infect macrophages, rather than T cells, and do not cause cells to fuse into a multinucleated syncytium. They are said to be M-tropic. Later in the infection, isolates infect T cells and do induce the formation of syncytia, and the emergence of this type of T-tropic HIV is accompanied by a decline in CD4+ lymphocytes and the development of AIDS. An important question, especially for therapy, is whether M-tropic viruses turn into T-tropic viruses, or whether the T-tropic strains are there all along, but either in very small numbers or suppressed. Some researchers have described dual-tropic isolates, which not only induce syncytia but also remain capable of infecting and multiplying within macrophages. These, it was conjectured, might be an intermediate step in the evolution of HIV during an infection. The different tropisms are the result of differences in the env protein of HIV. Doms's group created human cells that expressed either T-tropic or M-tropic env proteins. They mixed these with other cells expressing CD4 and either fusin or CKR-5. Bingo! T-tropic env fused only with fusin while M-tropic env would fuse only with CKR-5. What of dual-tropic strains? The env protein from one such isolate, called 89.6, was duly expressed in a cell, which proved able to fuse with both fusin and CKR-5 (in the presence of CD4, of course). (It also fused with two other b-chemokines, CKR-3 and CKR-2b, which neither purely T-tropic nor purely M-tropic env proteins responded to.) This is interesting because the extra-cellular domains of fusin and CKR-5 are not very similar (only 21% homology), while 89.6 env protein is around 90% homologous to well-characterized env proteins from T-tropic and M-tropic isolates, and no closer to either. This suggests that relatively subtle changes in the env protein underly the different tropisms; it also adds additional weight to the idea that M-tropic strains evolve into T-tropic ones as a result of changes to the env protein. As Gallo observed drily in the paper that set these particular hares
running, "These data may have relevance for the prevention and therapy of AIDS."
Of course, publishing in the penultimate issue of the year, Gallo had no chance to be seen
as among the hottest papers of 1995. Had he delayed two weeks he would have been way ahead
of the pack in 1996. But that's probably a poor reason to procrastinat. |
Science
writer Dr. Jeremy Cherfas
works with the Biotechnology and Biological Sciences
Research Council of the U.K., Swindon.
| Science
Watch®, January/February 1998, Vol. 9, No. 1 Citing URL: http://www.sciencewatch.com/jan-feb98/sw_jan-feb98_page8.htm |
Search | Jan/Feb 1998 Index | Archives | Contact | Home
|
|
|
|
|
Science
Watch® is an editorial component of Essential
Science Indicators |
|
|
|
(c) 2008 The
Thomson Corporation. |